1
de Wild, Sabine R., Simons, Janine M., Vrancken Peeters, Marie Jeanne T.F.D., Smidt, Marjolein L., Koppert, Linetta B.
Veröffentlicht in: de Wild , S R , Simons , J M , MINIMAX Group , Vrancken Peeters , M J T F D , Smidt , M L & Koppert , L B 2022 , ' MINImal vs. MAXimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer : Protocol of a Dutch Multicenter Registry Study (MINIMAX) ' , Clinical Breast Cancer , vol. 22 , no. 1 , pp. e59-e64 . https://doi.org/10.1016/j.clbc.2021.07.011;
2022
Veröffentlicht in: de Wild , S R , Simons , J M , MINIMAX Group , Vrancken Peeters , M J T F D , Smidt , M L & Koppert , L B 2022 , ' MINImal vs. MAXimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer : Protocol of a Dutch Multicenter Registry Study (MINIMAX) ' , Clinical Breast Cancer , vol. 22 , no. 1 , pp. e59-e64 . https://doi.org/10.1016/j.clbc.2021.07.011;
2022
2
3
de Wild, Sabine R., Koppert, Linetta B., de Munck, Linda, Peeters, Marie-Jeanne T. F. D. Vrancken, Siesling, Sabine, Smidt, Marjolein L., Simons, Janine M.
Veröffentlicht in: de Wild , S R , Koppert , L B , de Munck , L , Peeters , M-J T F D V , Siesling , S , Smidt , M L & Simons , J M 2024 , ' Prognostic effect of nodal status before and after neoadjuvant chemotherapy in breast cancer : a Dutch population-based study ' , Breast Cancer Research and Treatment , vol. 204 , no. 2 , pp. 277-288 . https://doi.org/10.1007/s10549-023-07178-6;
2024
Veröffentlicht in: de Wild , S R , Koppert , L B , de Munck , L , Peeters , M-J T F D V , Siesling , S , Smidt , M L & Simons , J M 2024 , ' Prognostic effect of nodal status before and after neoadjuvant chemotherapy in breast cancer : a Dutch population-based study ' , Breast Cancer Research and Treatment , vol. 204 , no. 2 , pp. 277-288 . https://doi.org/10.1007/s10549-023-07178-6;
2024
4
de Wild, Sabine R, de Munck, Linda, Simons, Janine M, Verloop, Janneke, van Dalen, Thijs, Elkhuizen, Paula H M, Houben, Ruud M A, van Leeuwen, A Elise, Linn, Sabine C, Pijnappel, Ruud M, Poortmans, Philip M P, Strobbe, Luc J A, Wesseling, Jelle, Voogd, Adri C, Boersma, Liesbeth J
Veröffentlicht in: de Wild , S R , de Munck , L , Simons , J M , Verloop , J , van Dalen , T , Elkhuizen , P H M , Houben , R M A , van Leeuwen , A E , Linn , S C , Pijnappel , R M , Poortmans , P M P , Strobbe , L J A , Wesseling , J , Voogd , A C & Boersma , L J 2022 , ' De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03) : 5-year follow-up results of a Dutch, prospective, registry study ' , Lancet oncology , vol. 23 , no. 9 , pp. 1201-1210 . https://doi.org/10.1016/S1470-2045(22)00482-X;
2022
Veröffentlicht in: de Wild , S R , de Munck , L , Simons , J M , Verloop , J , van Dalen , T , Elkhuizen , P H M , Houben , R M A , van Leeuwen , A E , Linn , S C , Pijnappel , R M , Poortmans , P M P , Strobbe , L J A , Wesseling , J , Voogd , A C & Boersma , L J 2022 , ' De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03) : 5-year follow-up results of a Dutch, prospective, registry study ' , Lancet oncology , vol. 23 , no. 9 , pp. 1201-1210 . https://doi.org/10.1016/S1470-2045(22)00482-X;
2022
5
de Wild, Sabine R., de Munck, Linda, Simons, Janine M., Verloop, Janneke, van Dalen, Thijs, Elkhuizen, Paula H.M., Houben, Ruud M.A., van Leeuwen, A. Elise, Linn, Sabine C., Pijnappel, Ruud M., Poortmans, Philip M.P., Strobbe, Luc J.A., Wesseling, Jelle, Voogd, Adri C., Boersma, Liesbeth J.
Veröffentlicht in: de Wild , S R , de Munck , L , Simons , J M , Verloop , J , van Dalen , T , Elkhuizen , P H M , Houben , R M A , van Leeuwen , A E , Linn , S C , Pijnappel , R M , Poortmans , P M P , Strobbe , L J A , Wesseling , J , Voogd , A C & Boersma , L J 2022 , ' De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03) : 5-year follow-up results of a Dutch, prospective, registry study ' , The Lancet Oncology , vol. 23 , no. 9 , pp. 1201-1210 . https://doi.org/10.1016/S1470-2045(22)00482-X;
2022
Veröffentlicht in: de Wild , S R , de Munck , L , Simons , J M , Verloop , J , van Dalen , T , Elkhuizen , P H M , Houben , R M A , van Leeuwen , A E , Linn , S C , Pijnappel , R M , Poortmans , P M P , Strobbe , L J A , Wesseling , J , Voogd , A C & Boersma , L J 2022 , ' De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03) : 5-year follow-up results of a Dutch, prospective, registry study ' , The Lancet Oncology , vol. 23 , no. 9 , pp. 1201-1210 . https://doi.org/10.1016/S1470-2045(22)00482-X;
2022